Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease
Lucas Liaudet, Csaba Szabó
Topics & Concepts
SpironolactoneMedicineMineralocorticoid receptorBlocking (statistics)Coronavirus disease 2019 (COVID-19)ReceptorMineralocorticoidSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDiseasePharmacologyAldosteroneInternal medicineBioinformaticsVirologyInfectious disease (medical specialty)BiologyStatisticsOutbreakMathematicsHormonal Regulation and HypertensionAdrenal Hormones and DisordersStress Responses and Cortisol